The search for safer, more effective medicines increasingly depends on understanding how biological systems respond to disease, genetic variation, and therapeutic interventions at the molecular level....
Read more
When companies evaluate GMP recombinant protein manufacturing, discussions often revolve around timelines, batch size or price per gram.
Read more
Making the transition from a laboratory-validated test to the industrial manufacture of rapid tests is one of the most critical stages in the life cycle of an in vitro diagnostic (IVD) product.
Read more
Purification is often where development programs stall: inadequate method design, suboptimal column selection, or a poor understanding of critical impurity profiles can consume months of development t...
Read more
Sterility testing is a core analytical competence at 3PBIOVIAN, with nearly three decades of experience analysing a wide range of product types, including protein‑based and viral products.
Read more
The way a clinical trial is communicated to patients determines its viability from the very outset. Before assessing inclusion criteria or protocol complexity, patients need to understand what is bein...
Read more
Clinical trials in the Intensive Care Units (ICUs) are among the most complex and demanding studies in clinical research. The scientific rationale for studying interventions in critically ill patients...
Read more
In the day-to-day conduct of clinical trials, one of the factors that most strongly affects patient recruitment and retention is not the scientific design of the protocol, but rather the indirect fina...
Read more
Partnership during the last 8 years leverages VIVEbiotech’s decade of experience manufacturing GMP ex- and in- vivo lentiviral vectors for the advanced therapies sector
Read more
Transfection-free stable producer cell line (SCL) offers easy scalability, reduction of cost of goods (COGs), improve vector quality, and low batch variability.
Read more
Managing a clinical trial with a limited population requires rethinking many of the usual assumptions of clinical research. When the number of potential patients is small, every methodological, operat...
Read more
Now advancing 15 next-generation in vivo therapies through high-performance, scalable lentiviral vector manufacturing capabilities
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
